SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006110
Filing Date
2020-05-11
Accepted
2020-05-11 07:35:29
Documents
86
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20200331x10q.htm 10-Q 2167874
2 EX-31.1 aplt-20200331ex31159fb6f.htm EX-31.1 12825
3 EX-31.2 aplt-20200331ex3129b2279.htm EX-31.2 12006
4 EX-32.1 aplt-20200331ex321a49083.htm EX-32.1 7865
5 EX-32.2 aplt-20200331ex322cafa2f.htm EX-32.2 7961
  Complete submission text file 0001558370-20-006110.txt   7654132

Data Files

Seq Description Document Type Size
6 EX-101.INS aplt-20200331.xml EX-101.INS 1539632
7 EX-101.SCH aplt-20200331.xsd EX-101.SCH 63255
8 EX-101.CAL aplt-20200331_cal.xml EX-101.CAL 48181
9 EX-101.DEF aplt-20200331_def.xml EX-101.DEF 203474
10 EX-101.LAB aplt-20200331_lab.xml EX-101.LAB 491079
11 EX-101.PRE aplt-20200331_pre.xml EX-101.PRE 410354
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 20862632
SIC: 2834 Pharmaceutical Preparations